IOMED, member of CataloniaBio & HealthTech and a leader in Artificial Intelligence for health data activation, has recently announced the closing of a €10 million Series A investment round.  

Philips Ventures - the investment group of healthcare technology leader Philips - and XTX Ventures - the investment arm of XTX Markets, a leading algorithmic trading firm - have led this financing round. Fondo Bolsa Social and Redseed also participated in the round, as did existing IOMED investors Adara Ventures and EASO Ventures.  

This objective represents the consolidation of the company as a benchmark in the sector, and is clear evidence of its unique and differential value proposition in the field of artificial intelligence. 

This investment round will allow IOMED to expand internationally, strengthen its position in the current market and reinforce the foundations for sustainable growth of the company.  

"We are at a turning point in the history of medicine, where artificial intelligence can make a significant difference" "Our mission is to be the catalyst that drives a better future for the healthcare ecosystem through the application of Artificial Intelligence". - Gabriel Maeztu (Co-Founder, CTO and Chairman of the Board). 

To achieve these objectives, IOMED has recently consolidated a strategic team, both at business and technological development level, key to lay the foundations of this project. Thus, IOMED has Pedro Cladera, with solid experience in large companies such as KPMG and Vueling, Montserrat Roura, who has more than 17 years of experience in Novartis and Antoni Mallol, with more than 30 years of experience in the hospital sector.  

The IOMED brand has also evolved, showing an updated image that reflects the company's maturity, innovative approach, and ongoing commitment to excellence and innovation in the healthcare sector. 

With this investment round and its focus on international expansion, IOMED consolidates its position as a benchmark in the field of artificial intelligence and innovation, and positions itself as a key ally in transforming the healthcare ecosystem.